Kiora Pharmaceuticals, Inc. - Common Stock — Cash Flow (NASDAQ:KPRX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -7.32 M-10.89 M-10.43 M-9.56 M8.56 M-9.96 M -8.51 M Cash from investing activities -244.44 K-157.02 K6 3750-22.66 M14.43 M 9.6 M Cash from financing activities 5 M17.8 M8.62 M5.97 M15.5 M265.65 K 4.92 M Free cash flow -7.32 M-10.89 M-10.43 M-9.56 M8.56 M-9.96 M -8.53 M

News

Kiora Pharmaceuticals adds retina specialist to advisory board

Kiora Pharmaceuticals receives new patent for KIO-100 formulations

Kiora Pharmaceuticals reports Q3 results, advances retinal disease trials

Kiora joins RARE-X Vision Consortium to advance rare eye disease research

Kiora pharma reports Q2 results, advances retinal disease trials

Vicarious Surgical appoints Stephen From as new CEO

Kiora Pharmaceuticals stock rises after receiving patent for KIO-104

Kiora Pharmaceuticals receives patent for ocular disease treatment

Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know

kiora pharmaceuticals reports results of annual shareholder meeting

Kiora Pharmaceuticals inks potential $110 million deal with Senju